Gold Silver Reports (GSR) – Cipla Share Price Gains On U.S. FDA Nod For Testosterone Injection – Shares of the Mumbai-based drugmaker rose as much as 1 percent to Rs 609 after U.S. FDA gave its final approval to Abbreviated New Drug Application (ANDA) fot Testosterone Cypionate injection.
Cipla’s Testosterone Cypionate injection is generic therapeutic equivalent version of Pharmacia and Upjohn’s DepoTestosterone. The drug is indicated for replacement therapy in males in conditions associated with symptoms of deficiency or absence of endogenous testosterone, the company said in an exchange notification.
Block Deal Alerts: Adani Ports Share Price Rises After Block Deal
✅ Infibeam had 20 lakh shares changed hands in a block deal. Stock down 1.2 percent at Rs 154.40.
✅ Adani Ports had 2.7 percent equity, or 5.52 crore shares changed hands in a block deal in pre-market trade. Stock up 1.54 percent at Rs 373.
